Financial Summary (All financials)
| In millions, except per share items | Jan-31-23 | Jan-31-22 | Jan-31-21 | Jan-31-20 |
| Revenues | 424.3 | 252.7 | 152.2 | 81.2 |
| Revenue growth | 68.0% | 66.0% | 87.3% | |
| Cost of goods sold | 51.7 | 30.0 | 18.5 | 9.4 |
| Gross profit | 372.7 | 222.7 | 133.7 | 71.9 |
| Gross margin | 87.8% | 88.1% | 87.9% | 88.5% |
| Sales and marketing | 310.0 | 190.8 | 154.1 | 99.2 |
| Research and development | 156.1 | 97.2 | 106.6 | 59.4 |
| General and administrative | 117.9 | 63.7 | 86.9 | 41.6 |
| EBITA | -209.0 | -128.3 | -213.7 | -128.4 |
| EBITA margin | -49.3% | -50.8% | -140.4% | -158.0% |
| Amortization of intangibles | 2.4 | 0.7 | 0.2 | |
| EBIT | -211.4 | -129.0 | -213.9 | -128.4 |
| EBIT margin | -49.8% | -51.0% | -140.6% | -158.0% |
| Pre-tax income | -175.3 | -159.1 | -189.4 | -129.5 |
| Income taxes | 2.9 | -1.5 | 2.8 | 1.2 |
| Tax rate | | 0.9% | | |
| Net income | -180.7 | -155.1 | -192.2 | -130.7 |
| Net margin | -42.6% | -61.4% | -126.3% | -161.0% |
| |
| Diluted EPS | | ($1.95) | ($3.82) | ($2.76) |
| Shares outstanding (diluted) | | 79.8 | 50.3 | 47.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|